EP3334824
PD-1 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.8.2016EP published:
17.11.2021EP application number:
16834640.1
EP translation filed:
3.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
8.8.2036Expiry date:
8.8.2026Next due date:
31.8.2026
Title in English:
PD-1 ANTIBODIESLanguage of the patent:
English
Timeline
Today
9.8.2016EP application
17.11.2021EP Publication
3.1.2022Translation submitted
15.2.2022Registration published
8.8.2026Expires
Owner
Name:
Innovent Biologics (Suzhou) Co., Ltd.Address:
168 Dongping Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN
Inventor
Name:
BARUAH, HemantaAddress:
Indianapolis, Indiana 46206-6288, US
Name:
CHEN, ChengAddress:
Indianapolis, Indiana 46206-6288, US
Name:
LIU, XiaolinAddress:
Indianapolis, Indiana 46206-6288, US
Name:
TSUN, AndyAddress:
Indianapolis, Indiana 46206-6288, US
Name:
YU, Dechao, M.Address:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2015/086494Date:
10.8.2015Country:
WO
Classification
Categories:
C12N 15/09, C12P 21/08, C07K 16/28, C12N 5/00, A61K 39/395, A61K 45/06, A61P 35/00, A61P 37/04, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.7.2022
Expires: 8.8.2023
Payer: Patice ehf.
Number: 8
Paid: 20.7.2023
Expires: 8.8.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.7.2024
Expires: 8.8.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.8.2025
Expires: 8.8.2026
Payer: Árnason Faktor ehf.